Xiaolong Alan Zhou

6PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Environmental epidemiologyMajor global burdens of diseaseOther biomedical and clinical sciences not elsewhere classifiedBehavioural epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 27, 2026
CD19 CAR T-cell therapy is feasible for patients with pemphigus vulgaris treated without lymphodepletion in the RESET-PV trial.

|Aug 13, 2025
An Acid-Oxidising Solution Containing Hypochlorous Acid Reduces Staphylococcus aureus and Improves Bacterial Diversity in Epidermolysis Bullosa Wounds.

Xiaolong A Zhou, Michael B Burns, Ziyou Ren

|Sep 30, 2024
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments.

Yanzhen Pang, William Q Nguyen, Liliana I Guerrero

|Jun 07, 2024
Updated cutaneous T-cell lymphoma TNMB staging criteria fail to identify patients with Sézary syndrome with low blood burden.

Lauren P Chrisman, Payton Fors Trimark, Yanzhen Pang

|Jun 06, 2022
Lifestyle, demographic and Skindex measures associated with cutaneous T-cell lymphoma: a single institution cohort study.

Morgan Nguyen, Tessa LeWitt, Yanzhen Pang

|Apr 02, 2022
Gut dysbiosis in cutaneous T-cell lymphoma is characterized by shifts in relative abundances of specific bacterial taxa and decreased diversity in more advanced disease.

M J Hooper, T M LeWitt, Y Pang

Pageof 1

Frequent Collaborators

2 joint publications

Lauren P Chrisman

2 joint publications

Yanzhen Pang

2 joint publications

William Q Nguyen

2 joint publications

Madeline J Hooper